Dipeptidyl peptidase 4 inhibitors

112 Pill - beige round, 8mm

Generic Name: sitagliptin

Pill with imprint 112 is Beige, Round and has been identified as Januvia 50 mg. It is supplied by Merck & Company Inc.

Januvia is used in the treatment of Diabetes, Type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Januvia (Sitagliptin [ si-ta-glip-tin ])-112-50 mg-Beige-Round
Januvia (Sitagliptin [ si-ta-glip-tin ])-112-50 mg-Beige-Round
Januvia (Sitagliptin [ si-ta-glip-tin ])-112-50 mg-Beige-Round
Januvia (Sitagliptin [ si-ta-glip-tin ])-112-50 mg-Beige-Round
Januvia (Sitagliptin [ si-ta-glip-tin ])-112-50 mg-Beige-Round
Januvia (Sitagliptin [ si-ta-glip-tin ])-112-50 mg-Beige-Round

Januvia
Generic Name: sitagliptin [ si-ta-glip-tin ]
Imprint: 112
Strength: 50 mg
Color: Beige
Size: 8.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Dipeptidyl peptidase 4 inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Calcium phosphate dibasic anhydrous, Croscarmellose sodium, Magnesium stearate, Microcrystalline cellulose, Ferric oxide red, Sodium stearyl fumarate, Magnesium silicate, Titanium dioxide, Ferric oxide yellow,
Latest News
Related Drugs